The medical service sector rose in the short term, Berry Genomics rose and stopped, and Novo Zhiyuan, Chengdu Pilot, Yakkang Biology, Hongbo Pharmaceutical, and Dian Diagnostics followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.